Insulet Price to Book Ratio 2010-2023 | PODD
Historical price to book ratio values for Insulet (PODD) over the last 10 years. The current price to book ratio for Insulet as of March 28, 2024 is 16.12.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Insulet Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-03-28 | 171.40 | 16.35 | |
2023-12-31 | 216.98 | $10.48 | 20.70 |
2023-09-30 | 159.49 | $8.70 | 18.33 |
2023-06-30 | 288.34 | $7.94 | 36.34 |
2023-03-31 | 318.96 | $7.21 | 44.21 |
2022-12-31 | 294.39 | $6.85 | 42.95 |
2022-09-30 | 229.40 | $6.16 | 37.21 |
2022-06-30 | 217.94 | $6.09 | 35.80 |
2022-03-31 | 266.39 | $6.44 | 41.34 |
2021-12-31 | 266.07 | $8.04 | 33.09 |
2021-09-30 | 284.23 | $7.22 | 39.34 |
2021-06-30 | 274.51 | $6.69 | 41.02 |
2021-03-31 | 260.92 | $8.84 | 29.52 |
2020-12-31 | 255.63 | $9.14 | 27.96 |
2020-09-30 | 236.59 | $9.03 | 26.19 |
2020-06-30 | 194.26 | $8.59 | 22.62 |
2020-03-31 | 165.68 | $0.94 | 177.08 |
2019-12-31 | 171.20 | $1.21 | 141.39 |
2019-09-30 | 164.93 | $2.44 | 67.68 |
2019-06-30 | 119.38 | $4.15 | 28.75 |
2019-03-31 | 95.09 | $3.75 | 25.36 |
2018-12-31 | 79.32 | $3.58 | 22.14 |
2018-09-30 | 105.95 | $3.35 | 31.62 |
2018-06-30 | 85.70 | $3.04 | 28.21 |
2018-03-31 | 86.68 | $2.90 | 29.84 |
2017-12-31 | 69.00 | $2.72 | 25.39 |
2017-09-30 | 55.08 | $1.28 | 43.14 |
2017-06-30 | 51.31 | $1.12 | 46.01 |
2017-03-31 | 43.09 | $1.10 | 39.25 |
2016-12-31 | 37.68 | $1.10 | 34.28 |
2016-09-30 | 40.94 | $1.13 | 36.11 |
2016-06-30 | 30.24 | $0.48 | 63.08 |
2016-03-31 | 33.16 | $0.46 | 71.74 |
2015-12-31 | 37.81 | $0.60 | 63.24 |
2015-09-30 | 25.91 | $0.97 | 26.75 |
2015-06-30 | 30.99 | $1.24 | 25.09 |
2015-03-31 | 33.35 | $1.42 | 23.42 |
2014-12-31 | 46.06 | $1.49 | 30.93 |
2014-09-30 | 36.85 | $1.43 | 25.70 |
2014-06-30 | 39.67 | $1.40 | 28.27 |
2014-03-31 | 47.42 | $2.22 | 21.39 |
2013-12-31 | 37.10 | $2.27 | 16.34 |
2013-09-30 | 36.24 | $2.23 | 16.27 |
2013-06-30 | 31.41 | $2.55 | 12.34 |
2013-03-31 | 25.86 | $2.43 | 10.64 |
2012-12-31 | 21.22 | $0.91 | 23.23 |
2012-09-30 | 21.58 | $1.05 | 20.58 |
2012-06-30 | 21.37 | $1.23 | 17.33 |
2012-03-31 | 19.14 | $1.47 | 13.01 |
2011-12-31 | 18.83 | $1.74 | 10.81 |
2011-09-30 | 15.26 | $1.76 | 8.67 |
2011-06-30 | 22.17 | $1.99 | 11.13 |
2011-03-31 | 20.62 | $1.30 | 15.81 |
2010-12-31 | 15.50 | $1.46 | 10.63 |
2010-09-30 | 14.14 | $0.83 | 16.95 |
2010-06-30 | 15.05 | $1.10 | 13.73 |
2010-03-31 | 15.09 | $1.08 | 13.99 |
2009-12-31 | 14.28 | $1.64 | 8.71 |
2009-09-30 | 11.23 | $0.01 | 1145.92 |
2009-03-31 | 4.10 | $0.56 | 7.38 |
2009-06-30 | 7.70 | $-0.12 | -61.90 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $11.830B | $1.697B |
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.909B | 25.56 |
Stryker (SYK) | United States | $136.478B | 33.84 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.969B | 29.70 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
Perrigo (PRGO) | Ireland | $4.263B | 12.19 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.78 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |